August 11, 2026

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Eyeing a 352% Potential Upside in Biotechnology

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is currently capturing the attention of investors with a remarkable potential upside of 352.62%, making it a compelling opportunity in the..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 78.96% Potential Upside in the Biotech Sector

Investors with an eye on the healthcare sector should take a closer look at Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the biotechnology industry...

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Biotech Growth Potential with 17.78% Upside

Travere Therapeutics, Inc. (TVTX), a prominent player in the biotechnology sector, is generating considerable interest among investors, particularly those focused on the healthcare space. With a..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Growth Potential Amid Strong Revenue Growth and Analyst Confidence

Aveanna Healthcare Holdings Inc (AVAH), a significant player in the healthcare sector, is drawing investor attention with its robust revenue growth and strong analyst confidence. With..

Envista Holdings Corporation (NVST) Investor Outlook: Analyzing a 8.45% Potential Upside in the Dental Sector

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector specializing in medical instruments and supplies, is capturing the attention of investors with its..

Artivion, Inc. (AORT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 60%

Artivion, Inc. (NYSE: AORT), a key player in the healthcare sector focusing on medical devices, has caught the attention of investors with its promising growth potential...

Harrow, Inc. (HROW) Stock Analysis: A 66% Potential Upside Awaits Investors in the Eyecare Pharmaceutical Space

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector and a specialized force in the drug manufacturing industry for specialty and generic ophthalmic products,..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Exploring a 41.95% Potential Upside in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is catching the eye of investors with its compelling potential upside of 41.95%, as reported by analysts. Specializing in precision medicine..

Neogen Corporation (NEOG) Stock Analysis: Assessing the 14% Potential Upside in Healthcare’s Niche Player

Neogen Corporation (NEOG), a key player in the healthcare sector, presents a compelling opportunity for investors looking for growth in the medical devices industry. With a..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 40% Potential Upside for Investors in Rare Disease Therapies

For investors with a keen eye on the biotechnology sector, Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) presents an intriguing opportunity, offering a significant 40.03% potential upside according..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Potential 15.51% Upside in the Biotech Arena

Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out in the biotech sector with its focus on neuromuscular diseases and innovative therapeutic solutions. With a market capitalization..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring the Innovative Potential of a $2.96 Billion Bioelectric Medicine Leader

Pulse Biosciences, Inc. (NASDAQ: PLSE), a leader in the burgeoning field of bioelectric medicine, has been making waves in the healthcare sector with its innovative approach..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring the 48.68% Potential Upside

For investors with an eye on the biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) stands out as a company to watch closely. With a market capitalization..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eye-Catching 39% Upside Potential

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) presents an intriguing opportunity for investors with its strong focus on ophthalmic pharmaceuticals and a promising 39.09% potential upside, according to..

Phreesia, Inc. (PHR): Growth Potential and Analyst Consensus for This Healthcare SaaS Innovator

Phreesia, Inc. (NASDAQ: PHR), a prominent player in the healthcare sector, specializes in providing a comprehensive SaaS-based software and payment platform. With its headquarters in Wilmington,..

Belite Bio, Inc (BLTE) Stock Analysis: Unveiling a 25.85% Upside Potential

Belite Bio, Inc (NASDAQ: BLTE) is capturing the attention of investors in the biotechnology sector with its promising clinical developments and a potential upside of 25.85%...

BGM Group Ltd. (BGM): Investor Outlook on a Healthcare Pioneer with 88.3% Revenue Growth

BGM Group Ltd. (BGM), a prominent player in China’s healthcare sector, particularly within the drug manufacturing industry, is drawing attention with its remarkable 88.3% revenue growth...

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a 8.32% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company renowned for its diverse portfolio of generic and proprietary injectable, inhalation, and intranasal products, might be flying under..

Viridian Therapeutics (VRDN) Stock Analysis: Unpacking the 58.82% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is making waves in the biotechnology sector with its innovative approach to developing treatments for serious and rare diseases. With a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring the 193% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its promising potential upside of 193.19%, making it a noteworthy contender in the biotechnology sector. Specializing..

Search

Funds

August 11, 2026

Search

Funds

August 11, 2026

FTSE 100

Funds